ATNM 经营现金流历史(2016–2025)
Actinium Pharmaceuticals, Inc. (ATNM) 年度经营现金流历史(来自 SEC 财报)—— 每个财年经营活动产生的现金净额。
-$24.6MFY2025 · FY2016 以来:-$20.8M → -$24.6M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$24.6M | +25.7% |
| FY2024 | -$33.1M | +30.1% |
| FY2023 | -$47.3M | -647.6% |
| FY2022 | $8.6M | +141.4% |
| FY2021 | -$20.9M | +3.5% |
| FY2020 | -$21.6M | -0.7% |
| FY2019 | -$21.5M | -4.3% |
| FY2018 | -$20.6M | +4.6% |
| FY2017 | -$21.6M | -3.7% |
| FY2016 | -$20.8M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议